| Date | Target | Acquirer | Sector | Deal Value / Multiple | Strategic Rationale |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **2024** | **VetriScience** (FoodScience) | Morgan Stanley Capital Partners | Companion | Undisclosed | **Platform Play**: Vet-channel dominance + manufacturing assets. Sponsor-to-sponsor exit (Wind Point). |
| **2024** | **Zoetis MFA Portfolio** | Phibro Animal Health | Livestock | $350M (~0.9x Rev) | **Scale**: Acquisition of regulated medicated feed additives to bolster Phibro’s core portfolio. |
| **2024** | **YuMOVE** (Lintbells) | Vetnique Labs (Gryphon) | Companion | ~5.5x Return (Inflexion) | **Cross-Border**: Merging US gut/gland health with UK’s #1 joint brand for transatlantic dominance. |
| **2023** | **Zesty Paws** | H&H Group | Companion | $610M (High Rev Multiple) | **Digital Native**: Acquiring the #1 Amazon supplement brand to capture e-commerce shifting volume. |
| **2023** | **Champion Petfoods** | Mars Petcare | Pet Food | Undisclosed | **Ultra-Premium**: Consolidating the "Biologically Appropriate" high-protein niche (Orijen/Acana). |
| **2022** | **NaturVet** | Swedencare | Companion | $447.5M (21.4x EBITDA) | **Manufacturing**: Gaining US soft-chew production capacity and retail footprint. |
| **2022** | **Delacon** | Cargill | Feed Additives | Undisclosed (Full Control) | **Phytogenics**: Betting on plant-based biologicals as the primary antibiotic replacement. |
| **2021** | **PetHonesty** | Vestar Capital | Companion | Undisclosed | **Omnichannel**: taking a DTC native brand into retail. |
| **2020** | **Erber Group** (Biomin) | DSM-Firmenich | Feed Additives | €980M (20-22x EBITDA) | **Mycotoxin & Gut**: The gold standard in mycotoxin deactivation technology. |
| **2018** | **Blue Buffalo** | General Mills | Pet Food | $8.0B (~22x EBITDA) | **Mass Premium**: The definitive exit that validated "natural" pet at CPG scale. |
| **2018** | **Neovia** | ADM | Feed | €1.5B | **Value-Add Premix**: Transforming ADM from commodity trader to specialty nutrition player. |
| **2017** | **Diamond V** | Cargill | Postbiotics | Undisclosed | **Immune Health**: Acquiring the original fermentation postbiotic for non-antibiotic health. |
